Example report. The whole genome example: a public genome from the 1000 Genomes Project, with CYP2D6 Structural Analysis, so you can see what yours will look like. Get your own report
13 medications in this reportExample report
Oncology
Chemotherapies · Estrogen Modulators
- Use as directed 13
The genes behind these labels
- UGT1A1Normal metabolizer*1/*60 · Read for 5, changes none
- CYP2D6Ultrarapid metabolizer*2/*2x2 · Read for 2, changes none
- DPYDNormal metabolizerReference/Reference · Read for 2, changes none
- NUDT15Normal metabolizer*1/*1 · Read for 2, changes none
- TPMTNormal metabolizer*1/*1 · Read for 2, changes none
- CYP2C19Intermediate metabolizer*1/*2 · Read for 1, changes none
- CYP2C9Intermediate metabolizer*1/*8 · Read for 1, changes none
The oncology by label
Open any medication for the results behind its label and the guidelines in full.
Use as directed 13 medications
- BelinostatBeleodaq Chemotherapies Use as directed Your body processes belinostat at a normal rate. The standard dose should work as expected.UGT1A1Normal metabolizer
- BelzutifanWelireg Chemotherapies Use as directed Your CYP2C19 result means somewhat lower CYP2C19 activity than usual, but the FDA gives no genetic dosing change for belzutifan at this result.CYP2C19Intermediate metabolizer
- CapecitabineXeloda, Xitabin, Kapetral Chemotherapies Use as directed Your body processes capecitabine normally. You have a typical risk of side effects, and the standard dose is expected to be appropriate.DPYDNormal metabolizer
- ErdafitinibBalversa Chemotherapies Use as directed Your CYP2C9 result means somewhat lower CYP2C9 activity than usual, but the FDA gives no genetic dosing change for erdafitinib at this result.CYP2C9Intermediate metabolizer
- FluorouracilAdrucil, Carac Chemotherapies Use as directed Your body breaks down this drug normally. Your risk of side effects is typical, and the usual dose is used.DPYDNormal metabolizer
- GefitinibIressa Chemotherapies Use as directed Your CYP2D6 result means higher CYP2D6 activity than usual, but the FDA gives no genetic dosing change for gefitinib at this result.CYP2D6Ultrarapid metabolizer
- IrinotecanCamptosar, Onivyde Chemotherapies Use as directed Your body processes irinotecan at a normal rate. The standard dose should work as expected.UGT1A1Normal metabolizer
- MercaptopurinePurinethol Chemotherapies Use as directed Both genes that affect this drug look normal, so a standard starting dose is expected.TPMTNormal metabolizerNUDT15Normal metabolizer
- NilotinibTasigna Chemotherapies Use as directed Your body processes nilotinib at a normal rate. The standard dose should work as expected.UGT1A1Normal metabolizer
- PazopanibVotrient Chemotherapies Use as directed Your body processes pazopanib at a normal rate. The standard dose should work as expected.UGT1A1Normal metabolizer
- Sacituzumab Govitecan-HziyTrodelvy Chemotherapies Use as directed Your body processes sacituzumab govitecan at a normal rate. The standard dose should work as expected.UGT1A1Normal metabolizer
- ThioguanineLanvis, Tabloid Chemotherapies Use as directed Both genes that affect this drug look normal, so a standard starting dose is expected.TPMTNormal metabolizerNUDT15Normal metabolizer
- TamoxifenNolvadex, Soltamox Estrogen Modulators Use as directed Your body turns this drug into its active form well. The usual dose should work.CYP2D6Ultrarapid metabolizer
Don't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.